| meta-analysis | Q815382 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Andrew C. Hayward | Q21337729 |
| Laura J Shallcross | Q53678289 | ||
| Ellen B Fragaszy | Q56241072 | ||
| P2093 | author name string | Anne M Johnson | |
| P2860 | cites work | Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence | Q24598936 |
| Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia | Q28145964 | ||
| Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia | Q28260215 | ||
| Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes | Q28264116 | ||
| Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection | Q28264364 | ||
| Methicillin resistance in staphylococci | Q79537912 | ||
| Clinical features, epidemiology, antimicrobial resistance, and exotoxin genes (including that of Panton-Valentine leukocidin) of gentamicin-susceptible methicillin-resistant Staphylococcus aureus (GS-MRSA) isolated at a paediatric teaching hospital | Q79987533 | ||
| Throat swabs are necessary to reliably detect carriers of Staphylococcus aureus | Q80634039 | ||
| Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients | Q81167387 | ||
| Clinical and epidemiological features of upper-extremity infections caused by Staphylococcus aureus carrying the PVL gene: a four-year study in Greece | Q82179733 | ||
| Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? | Q28274375 | ||
| Screening, isolation, and decolonisation strategies in the control of meticillin resistant Staphylococcus aureus in intensive care units: cost effectiveness evaluation | Q28744168 | ||
| STAPHYLOCOCCAL TOXIN. | Q29040204 | ||
| Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. | Q30228973 | ||
| Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. | Q30350486 | ||
| Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve | Q33181940 | ||
| Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis | Q33369089 | ||
| Community-associated Staphylococcus aureus infections and nasal carriage among children: molecular microbial data and clinical characteristics | Q33371052 | ||
| Factors predicting and reducing mortality in patients with invasive Staphylococcus aureus disease in a developing country | Q33490115 | ||
| Rapid detection of Staphylococcus aureus Panton-Valentine leukocidin in clinical specimens by enzyme-linked immunosorbent assay and immunochromatographic tests | Q33769542 | ||
| Association of recurrent furunculosis with Panton-Valentine leukocidin and the genetic background of Staphylococcus aureus | Q33827232 | ||
| Staphylococcus aureus isolates carrying Panton-Valentine leucocidin genes in England and Wales: frequency, characterization, and association with clinical disease | Q33858913 | ||
| Incidence, risk factors, and outcomes of Panton-Valentine leukocidin-positive methicillin-susceptible Staphylococcus aureus infections in Auckland, New Zealand. | Q34190342 | ||
| Severe Staphylococcus aureus Infections Caused by Clonally Related Community-Acquired Methicillin-Susceptible and Methicillin-Resistant Isolates | Q34267132 | ||
| A clone of methicillin-resistant Staphylococcus aureus among professional football players. | Q34390668 | ||
| Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children | Q34452894 | ||
| Molecular distinctions exist between community-associated methicillin-resistant Staphylococcus aureus colonization and disease-associated isolates in children | Q34798700 | ||
| Frequency of panton-valentine leukocidin-producing methicillin-sensitive Staphylococcus strains in patients with complicated skin and soft tissue infection in bronx, new york | Q35139743 | ||
| Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. | Q35613159 | ||
| Diversity among community isolates of methicillin-resistant Staphylococcus aureus in Australia. | Q35714895 | ||
| Methicillin-resistant Staphylococcus aureus in children, Taiwan | Q35793200 | ||
| Presence of genes encoding panton-valentine leukocidin is not the primary determinant of outcome in patients with hospital-acquired pneumonia due to Staphylococcus aureus | Q35806964 | ||
| The emergence and importation of diverse genotypes of methicillin-resistant Staphylococcus aureus (MRSA) harboring the Panton-Valentine leukocidin gene (pvl) reveal that pvl is a poor marker for community-acquired MRSA strains in Ireland | Q35947452 | ||
| Staphylococcus aureus colonization among household contacts of patients with skin infections: risk factors, strain discordance, and complex ecology | Q35948772 | ||
| Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial | Q36095019 | ||
| Community-associated meticillin-resistant Staphylococcus aureus | Q36438720 | ||
| Effectiveness of measures to eradicate Staphylococcus aureus carriage in patients with community-associated skin and soft-tissue infections: a randomized trial | Q36482018 | ||
| Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: A perspective for Canadian health care practitioners | Q36563779 | ||
| Proposed definitions of community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA). | Q36899299 | ||
| Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease | Q36953300 | ||
| Increasing hospitalizations and general practice prescriptions for community-onset staphylococcal disease, England. | Q37009085 | ||
| Community strains of methicillin-resistant Staphylococcus aureus as potential cause of healthcare-associated infections, Uruguay, 2002-2004. | Q37009576 | ||
| Biogeography and virulence of Staphylococcus aureus. | Q37250160 | ||
| Community-associated methicillin-resistant Staphylococcus aureus isolated in Finland in 2004 to 2006 | Q37302081 | ||
| Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe | Q37718313 | ||
| Community-associated meticillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated infection | Q37899352 | ||
| Clinical isolates of Pantone-Valentine leucocidin- and gamma-haemolysin-producing Staphylococcus aureus: prevalence and association with clinical infections | Q39247142 | ||
| Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections | Q39744021 | ||
| Clinical isolates of Staphylococcus aureus from the Arkhangelsk region, Russia: antimicrobial susceptibility, molecular epidemiology, and distribution of Panton-Valentine leukocidin genes | Q39868763 | ||
| Identification of staphylococcal Panton-Valentine leukocidin as a potent dermonecrotic toxin. | Q41164720 | ||
| Epidemiology of methicillin-susceptible Staphylococcus aureus lineages in five major African towns: high prevalence of Panton-Valentine leukocidin genes. | Q41432945 | ||
| Phenotypic prediction rule for community-associated methicillin-resistant Staphylococcus aureus | Q41896741 | ||
| Clinical correlates of Panton-Valentine leukocidin (PVL), PVL isoforms, and clonal complex in the Staphylococcus aureus population of Northern Australia. | Q42956436 | ||
| Decrease in Staphylococcus aureus colonization and hospital-acquired infection in a medical intensive care unit after institution of an active surveillance and decolonization program | Q42995744 | ||
| Transcription of inflammatory genes in the lung after infection with community-associated methicillin-resistant Staphylococcus aureus: a role for panton-valentine leukocidin? | Q43128011 | ||
| Community-acquired, methicillin-resistant Staphylococcus aureus isolated from children with community-onset pneumonia in China | Q43174286 | ||
| Preventing surgical-site infections in nasal carriers of Staphylococcus aureus | Q43201082 | ||
| Should we screen and decolonise contacts of patients with Panton Valentine leukocidin associated Staphylococcus aureus infection? | Q43418660 | ||
| Case definition for community-associated methicillin-resistant Staphylococcus aureus | Q43592291 | ||
| Leukocidin from Staphylococcus aureus and cutaneous infections: an epidemiologic study | Q43856457 | ||
| Methicillin-resistant Staphylococcus aureus in the Australian community: an evolving epidemic | Q44032053 | ||
| Clinical and laboratory features of invasive community-onset methicillin-resistant Staphylococcus aureus infection: a prospective case-control study | Q44261574 | ||
| Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections--Los Angeles County, California, 2002-2003. | Q44316280 | ||
| Coexistence of Panton-Valentine leukocidin-positive and -negative community-associated methicillin-resistant Staphylococcus aureus USA400 sibling strains in a large Canadian health-care region | Q44530943 | ||
| Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. | Q44836980 | ||
| In vitro production of panton-valentine leukocidin among strains of methicillin-resistant Staphylococcus aureus causing diverse infections | Q44884193 | ||
| Community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus musculoskeletal infections in children | Q45007740 | ||
| Detection of Panton-Valentine leukocidin gene in Staphylococcus aureus by LightCycler PCR: clinical and epidemiological aspects | Q45063480 | ||
| Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers | Q45097034 | ||
| Virulence factors and genotypes of Staphylococcus aureus from infection and carriage in Gabon | Q45212831 | ||
| High incidence of Panton-Valentine leukocidin-producing Staphylococcus aureus in a tertiary care public hospital in Singapore | Q45237068 | ||
| Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections. | Q46036617 | ||
| Comparison of community-associated methicillin-resistant Staphylococcus aureus from teaching hospitals in London and the USA, 2004-2006: where is USA300 in the UK? | Q46147094 | ||
| Methicillin-resistant Staphylococcus aureus (MRSA) in hospitalized children: correlation of molecular analysis with clinical presentation and antibiotic susceptibility testing (ABST) results | Q46236867 | ||
| Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles | Q46426023 | ||
| The emergence of community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital, 2000-2006. | Q46536134 | ||
| Methicillin-susceptible, non-multiresistant methicillin-resistant and multiresistant methicillin-resistant Staphylococcus aureus infections: a clinical, epidemiological and microbiological comparative study. | Q46751296 | ||
| Spread of Staphylococcus aureus clinical isolates carrying Panton-Valentine leukocidin genes during a 3-year period in Greece | Q46929772 | ||
| Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus — Minnesota and North Dakota, 1997-1999 | Q47777263 | ||
| The nose is not the only relevant MRSA screening site | Q49172424 | ||
| Utility of antimicrobial susceptibility-based algorithms for the presumptive identification of genotypically-defined community-associated methicillin-resistant Staphylococcus aureus at a London teaching hospital | Q51644498 | ||
| Panton-Valentine leukocidin associated staphylococcal disease: a cross-sectional study at a London hospital, England. | Q53165515 | ||
| Staphylococcus aureus pneumonia in children in the era of community-acquired methicillin-resistance at Texas Children's Hospital. | Q54383001 | ||
| Staphylococcus aureus skin/soft-tissue infections: the impact of SCCmec type and Panton-Valentine leukocidin. | Q54509288 | ||
| Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus. | Q54579067 | ||
| Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department | Q55897489 | ||
| Factors Predicting Mortality in Necrotizing Community-Acquired Pneumonia Caused by Staphylococcus aureus Containing Panton-Valentine Leukocidin | Q58441900 | ||
| Pediatric Bone and Joint Infections Caused by Panton-Valentine Leukocidin-Positive Staphylococcus aureus | Q58441965 | ||
| Epidemiology of non-multiresistant methicillin-resistant Staphylococcus aureus infection in Queensland, Australia: associations with indigenous populations and Panton–Valentine leukocidin | Q63859716 | ||
| Severity of Disease and Clinical Outcomes in Patients With Hospital-Acquired Pneumonia Due to Methicillin-Resistant Staphylococcus aureus Strains Not Influenced by the Presence of the Panton-Valentine Leukocidin Gene | Q64133337 | ||
| P433 | issue | 1 | |
| P921 | main subject | membrane protein | Q423042 |
| bacteria | Q10876 | ||
| meta-analysis | Q815382 | ||
| systematic review | Q1504425 | ||
| P304 | page(s) | 43-54 | |
| P577 | publication date | 2012-10-26 | |
| 2013-01-01 | |||
| P1433 | published in | Lancet Infectious Diseases | Q15724248 |
| P1476 | title | The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-analysis | |
| P478 | volume | 13 |
| Q38818388 | A 3-year long study of Staphylococcus aureus isolates from subclinical mastitis in three Azawak zebu herds at the Sahelian experimental farm of Toukounous, Niger |
| Q88797262 | A common approach to toxin specificity |
| Q41668714 | A new lipase as a pharmaceutical target for battling infections caused by Staphylococcus aureus: Gene cloning and biochemical characterization |
| Q64055549 | Accessory gene regulator (agr) dysfunction was unusual in Staphylococcus aureus isolated from Chinese children |
| Q93146708 | Acute Hematogenous Osteomyelitis in Children |
| Q36207026 | Antibiotic resistance and clonal diversity of invasive Staphylococcus aureus in the rural Ashanti Region, Ghana |
| Q92237018 | Association of pvl gene with incomplete hemolytic phenotype in clinical Staphylococcus aureus |
| Q92727222 | CASSETTE-clindamycin adjunctive therapy for severe Staphylococcus aureus treatment evaluation: study protocol for a randomised controlled trial |
| Q57824710 | Characterization of Panton-Valentine leukocidin-positive from skin and soft tissue infections and wounds in Nigeria: a cross-sectional study |
| Q47647339 | Characterization of Staphylococcus aureus isolated from patients with burns in a regional burn center, Southeastern China |
| Q39249431 | Clinical and molecular epidemiology of community-onset invasive Staphylococcus aureus infection in New Zealand children |
| Q35053423 | Co-detection of Panton-Valentine leukocidin encoding genes and cotrimoxazole resistance in Staphylococcus aureus in Gabon: implications for HIV-patients' care |
| Q64107800 | Coagulase-Negative Staphylococci Pathogenomics |
| Q26824167 | Community-acquired necrotizing pneumonia caused by methicillin-resistant Staphylococcus aureus producing Panton-Valentine leukocidin in a Chinese teenager: case report and literature review |
| Q33822603 | Comparison of methicillin-resistant Staphylococcus aureus community-acquired and healthcare-associated pneumonia |
| Q28552176 | Detection of Alpha-Toxin and Other Virulence Factors in Biofilms of Staphylococcus aureus on Polystyrene and a Human Epidermal Model |
| Q35737755 | Development of a heptaplex PCR assay for identification of Staphylococcus aureus and CoNS with simultaneous detection of virulence and antibiotic resistance genes |
| Q40092261 | Diagnosis and management of Panton-Valentine leukocidin toxin associated Staphylococcus aureus infection: an update |
| Q35864500 | Differential Interaction of the Staphylococcal Toxins Panton-Valentine Leukocidin and γ-Hemolysin CB with Human C5a Receptors |
| Q35983355 | Direct molecular versus culture-based assessment of Gram-positive cocci in biopsies of patients with major abscesses and diabetic foot infections |
| Q92987917 | Distribution of Toxinogenic Methicillin-Resistant and Methicillin-Susceptible Staphylococcus aureus from Different Ecological Niches in Algeria |
| Q49540268 | Distribution of sasX, pvl, and qacA/B genes in epidemic methicillin-resistant Staphylococcus aureus strains isolated from East China |
| Q89629088 | Diversity of bacteriophages encoding Panton-Valentine leukocidin in temporally and geographically related Staphylococcus aureus |
| Q54637867 | Emergence of methicillin resistance and Panton-Valentine leukocidin positivity in hospital- and community-acquired Staphylococcus aureus infections in Beira, Mozambique. |
| Q89996231 | Epidemiological Characteristics of Staphylococcus Aureus in Raw Goat Milk in Shaanxi Province, China |
| Q34979082 | Epidemiological, clinical, outcome and antibiotic susceptibility differences between PVL positive and PVL negative Staphylococcus aureus infections in Western Australia: a case control study |
| Q34999500 | Epidemiology and outcome of pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitals |
| Q35070917 | Expression of Panton-Valentine leukocidin mRNA among Staphylococcus aureus isolates associates with specific clinical presentations |
| Q90283299 | Frequency of Panton-Valentine Leukocidin Gene among Clinical Isolates of Methicillin-Resistant Staphylococcus aureus in Eastern Province of Saudi Arabia |
| Q47817710 | Fulminant peritonitis presumably caused by Panton-Valentine leukocidin-positive Staphylococcus aureus in a girl on peritoneal dialysis |
| Q35058098 | Genetic Diversity of Staphylococcus aureus in Buruli Ulcer |
| Q64084689 | Genomic and Epidemiological Evidence of a Dominant Panton-Valentine Leucocidin-Positive Methicillin Resistant Lineage in Sri Lanka and Presence Among Isolates From the United Kingdom and Australia |
| Q37251526 | High Nasal Carriage Rate of Staphylococcus aureus Containing Panton-Valentine leukocidin- and EDIN-Encoding Genes in Community and Hospital Settings in Burkina Faso |
| Q33776238 | High burden of complicated skin and soft tissue infections in the Indigenous population of Central Australia due to dominant Panton Valentine leucocidin clones ST93-MRSA and CC121-MSSA. |
| Q54218740 | Human CD45 is an F-component-specific receptor for the staphylococcal toxin Panton-Valentine leukocidin. |
| Q40537073 | Humanized Mice Exhibit Increased Susceptibility to Staphylococcus aureus Pneumonia. |
| Q33634034 | Humanized Mouse Models of Staphylococcus aureus Infection. |
| Q38104279 | Impact of community-associated methicillin resistant Staphylococcus aureus on HIV-infected patients |
| Q40155457 | In Situ Capture of Bacterial Toxins for Antivirulence Vaccination |
| Q55262876 | In Vitro generation of Panton-Valentine leukocidin (PVL) in clinical Methicillin-Resistant Staphylococcus aureus (MRSA) and its correlation with PVL variant, clonal complex, infection type. |
| Q37487573 | Increased Age-Dependent Risk of Death Associated With lukF-PV-Positive Staphylococcus aureus Bacteremia |
| Q94562624 | Intensive Care Society State of the Art 2018 Abstracts |
| Q31164686 | Kineret®/IL-1ra blocks the IL-1/IL-8 inflammatory cascade during recombinant Panton Valentine Leukocidin-triggered pneumonia but not during S. aureus infection |
| Q52318491 | Management of superficial and deep-seated Staphylococcus aureus skin and soft tissue infections in sub-Saharan Africa: a post hoc analysis of the StaphNet cohort. |
| Q93160786 | Marked increase in community-associated methicillin-resistant Staphylococcus aureus infections, Western Australia, 2004-2018 |
| Q38182023 | Methicillin-resistant Staphylococcus aureus as a cause of invasive infections in Central Africa: a case report and review of the literature |
| Q64973362 | Methicillin-resistant Staphylococcus aureus colonization and infection risks from companion animals: current perspectives. |
| Q35766592 | Molecular Characterization and Antimicrobial Susceptibility of Staphylococcus aureus Isolates from Clinical Infection and Asymptomatic Carriers in Southwest Nigeria. |
| Q38748268 | Molecular Characterization of Staphylococcus aureus Isolates From Children With Periorbital or Orbital Cellulitis |
| Q92139837 | Molecular Epidemiology of Staphylococcus aureus in Skin and Soft Tissue Infections and Bone and Joint Infections in Korean Children |
| Q64882264 | Molecular characteristics and clinical features of pediatric methicillin-susceptible Staphylococcus aureus infection in a medical center in northern Taiwan. |
| Q43527413 | Molecular characteristics of Staphylococcus aureus associated with chronic rhinosinusitis |
| Q37336172 | Molecular characterization of Staphylococcus aureus and influenza virus coinfections in patients with fatal Pneumonia |
| Q27006781 | Molecular epidemiology of Methicillin-resistant Staphylococcus aureus in Africa: a systematic review |
| Q92237053 | Molecular typing revealed the emergence of pvl-positive sequence type 22 methicillin-susceptible Staphylococcus aureus in Urumqi, Northwestern China |
| Q38170983 | Mortality among patients with methicillin-resistant Staphylococcus aureus USA300 versus non-USA300 invasive infections: a meta-analysis |
| Q38645380 | Necrotizing pneumonia: an emerging problem in children? |
| Q64260103 | Outbreak report of investigation and control of an outbreak of Panton-Valentine Leukocidin-positive methicillin-sensitive Staphylococcus aureus (PVL-MSSA) infection in neonates and mothers |
| Q39138001 | Paediatric Bone and Joint Infections in French Guiana: A 6 Year Retrospective Review |
| Q47110379 | Panton-Valentine Leucocidin (PVL) as a Potential Indicator for Prevalence, Duration, and Severity of Staphylococcus aureus Osteomyelitis |
| Q49223126 | Panton-Valentine Leukocidin associated with S. aureus osteomyelitis activates platelets via neutrophil secretion products |
| Q43492418 | Panton-Valentine leucocidin and pneumonia--authors' reply |
| Q50870970 | Panton-Valentine leucocidin and pneumonia. |
| Q64110275 | Panton-Valentine leucocidin is the key determinant of pyomyositis in a bacterial GWAS |
| Q35613368 | Panton-Valentine leukocidin in community and hospital-acquired Staphylococcus aureus strains |
| Q38316974 | Panton-Valentine leukocidin osteomyelitis in children: a growing threat |
| Q56746226 | Periorbital infections and conjunctivitis due to Panton-Valentine Leukocidin (PVL) positive Staphylococcus aureus in children |
| Q33806504 | Predictors of Adverse Outcomes in Children With Staphylococcus aureus Bacteremia |
| Q64084638 | Prevalence and Characterization of Isolated From Pasteurized Milk in China |
| Q38641027 | Prevalence and Genetic Characteristics of Staphylococcus aureus and Staphylococcus argenteus Isolates Harboring Panton-Valentine Leukocidin, Enterotoxins, and TSST-1 Genes from Food Handlers in Myanmar |
| Q92704100 | Prevalence of Panton-Valentine Leukocidin (PVL) and Antimicrobial Resistance in Community-Acquired Clinical Staphylococcus aureus in an Urban Gambian Hospital: A 11-Year Period Retrospective Pilot Study |
| Q36104341 | Prevalence of nasal colonisation by methicillin-sensitive and methicillin-resistant Staphylococcus aureus among healthcare workers and students in Madagascar |
| Q64105208 | Preventing lung pathology and mortality in rabbit Staphylococcus aureus pneumonia models with cytotoxin-neutralizing monoclonal IgGs penetrating the epithelial lining fluid |
| Q34143887 | Prostatic abscesses and severe sepsis due to methicillin-susceptible Staphylococcus aureus producing Panton-Valentine leukocidin |
| Q47098119 | Pyoderma outbreak among kindergarten families: Association with a Panton-Valentine leukocidin (PVL)-producing S. aureus strain |
| Q92437174 | Real-time PCR assay for detection of Staphylococcus aureus, Panton-Valentine Leucocidin and Methicillin Resistance directly from clinical samples |
| Q38931393 | Recurrent skin infection associated with nasal carriage of Panton-Valentine leukocidin-positive methicillin-susceptible Staphylococcus aureus closely related to the EMRSA-15 clone |
| Q92889436 | Regulation of Staphylococcus aureus Virulence |
| Q90372157 | Severe infections of Panton-Valentine leukocidin positive Staphylococcus aureus in children |
| Q36325816 | Short-term increase in prevalence of nasopharyngeal carriage of macrolide-resistant Staphylococcus aureus following mass drug administration with azithromycin for trachoma control |
| Q37367114 | Staphylococcal Cassette Chromosome mec Types Among Methicillin-Resistant Staphylococcus aureus in Northern Iran |
| Q38193690 | Staphylococcal bicomponent pore-forming toxins: targets for prophylaxis and immunotherapy |
| Q89661806 | Staphylococcal species less frequently isolated from human clinical specimens - are they a threat for hospital patients? |
| Q26741281 | Staphylococcus aureus Toxins and Diabetic Foot Ulcers: Role in Pathogenesis and Interest in Diagnosis |
| Q42260635 | Staphylococcus aureus abscesses: methicillin-resistance or Panton-Valentine leukocidin presence? |
| Q36979233 | Staphylococcus aureus corneal infections: effect of the Panton-Valentine leukocidin (PVL) and antibody to PVL on virulence and pathology |
| Q34478074 | Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. |
| Q39264668 | Staphylococcus aureus pore-forming toxins: The interface of pathogen and host complexity |
| Q94464354 | Studying Staphylococcal Leukocidins: A Challenging Endeavor |
| Q40065964 | Subinhibitory Dalbavancin Attenuates Exotoxin Production from Methicillin-sensitive and Methicillin-resistant Staphylococcus aureus in vitro |
| Q54254468 | Subscapularis pyomyositis: a rare presentation of shoulder pain. |
| Q38958617 | Surface and Exoproteomes of Gram-Positive Pathogens for Vaccine Discovery |
| Q50016545 | Survey of Staphylococcus aureus in a general pediatric population and focus on isolates with three clinically relevant toxin-encoding genes |
| Q89075826 | The Concern for Vancomycin Failure in the Treatment of Pediatric Staphylococcus aureus Disease |
| Q36097974 | The Epidemiology of Staphylococcus aureus and Panton-Valentine Leucocidin (pvl) in Central Australia, 2006-2010. |
| Q40050138 | The Impact of the Staphylococcus aureus Virulome on Infection in a Developing Country: A Cohort Study |
| Q92853675 | The Role of Streptococcal and Staphylococcal Exotoxins and Proteases in Human Necrotizing Soft Tissue Infections |
| Q33743499 | The bicomponent pore-forming leucocidins of Staphylococcus aureus |
| Q47219068 | The multistep road to ventilator-associated lung abscess: A retrospective study of S.aureus ventilator-associated pneumonia |
| Q35677499 | Transmission and microevolution of USA300 MRSA in U.S. households: evidence from whole-genome sequencing |
| Q37148705 | Typing of Panton-Valentine Leukocidin-Encoding Phages and lukSF-PV Gene Sequence Variation in Staphylococcus aureus from China |
| Q39392178 | Use of bacterial whole-genome sequencing to understand and improve the management of invasive Staphylococcus aureus infections |
| Q91935198 | [Panton-valentine leukocidin (PVL)-positive Staphylococcus aureus causing necrotizing pneumonia after infection with parainfluenza virus type 2] |
Search more.